Screener
ABVC BioPharma, Inc. ABVC Q4 2025 earnings
Reported March 3, 2026 · Before market open
Revenue-$796.0K
EPS-$0.12
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$113.3K
EPS estimate-$0.40
Versus estimates
Revenue
Q4 2025-$796.0K
Q3 2025$796.0KDiluted EPS
FAQ
- When did ABVC BioPharma, Inc. report Q4 2025 earnings?
- ABVC BioPharma, Inc. (ABVC) reported Q4 2025 earnings on March 3, 2026 before market open.
- What were ABVC BioPharma, Inc.'s Q4 2025 revenue and EPS?
- ABVC BioPharma, Inc. reported revenue of -$796.0K and eps of $-0.12 for Q4 2025.
- How did ABVC BioPharma, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 40606.4% from $2.0K a year earlier.
- Where can I find ABVC BioPharma, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-26-023054) and the 10-Q/A periodic report (0001213900-26-023062) directly on SEC EDGAR. The filing index links above go to sec.gov.
